๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of a closure device on complication rates in high-local-risk patients: Results of a randomized multicenter trial

โœ Scribed by Bernard Chevalier; Bernard Lancelin; Rene Koning; Michel Henry; Antoine Gommeaux; Remy Pilliere; Meyer Elbaz; Thierry Lefevre; Kamel Boughalem; Jean Marco; Patrick Dupouy


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
75 KB
Volume
58
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Impact of high-dose peginterferon alfa-2
โœ Stuart K. Roberts; Martin D. Weltman; Darrell H. G. Crawford; Geoffrey W. McCaug ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 339 KB ๐Ÿ‘ 2 views

This study tested the hypothesis that high-dose peginterferon alfa-2a (PEG-IFNalpha-2a) for the first 12 weeks would increase early and sustained virological response (SVR) rates in patients with chronic hepatitis C genotype 1. Eight hundred ninety-six patients were randomized 1:1 to 360 microg (n =

Efficacy and safety of high-dose pravast
โœ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place